• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种快速且经过验证的 GC-MS/MS 方法,用于同时定量血清肌醇和 D-手性肌醇异构体。

A rapid and validated GC-MS/MS method for simultaneous quantification of serum Myo- and D-chiro-inositol isomers.

机构信息

Department of Laboratory Medicine, the Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China; Department of Clinical Laboratory, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, Zhejiang Province, 318000, China.

Physical and chemical laboratory of Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan 410005, China.

出版信息

J Chromatogr A. 2024 Sep 13;1732:465246. doi: 10.1016/j.chroma.2024.465246. Epub 2024 Aug 8.

DOI:10.1016/j.chroma.2024.465246
PMID:39128239
Abstract

BACKGROUND

Myo-inositol (MI) and D-chiro-inositol (DCI) are two paramount isomers of inositol, both vital in glucose and steroid metabolism. Deficits in MI, DCI or MI/DCI ratio are expressly concerned with several pathological process, whereas MI and DCI lack practical measurement for human specimen.

METHODS

To quantify MI and DCI in serum samples simultaneously, a gas chromatography tandem mass spectrometry (GC-MS/MS) method was established. The process flow was optimized in ion source, derivative agent volume and reaction time. The performance characteristics were verified by commercial standards and clinical serums.

RESULTS

This method was confirmed to be sensitive (LOD ≤ 30 ng/mL of MI, ≤3 ng/mL of DCI) and reproducible (RSD < 6 % for repeated analyses). Quantitative determinations performed good linearity within the measurement range of 0.500-10.00 and 0.005-0.500 μg/mL for MI and DCI respectively (R > 0.999). The recoveries of MI and DCI were 97.11-99.35 % and 107.82-113.09 %, respectively. This method was successfully applied to 114 clinical specimens. No significant matrix effect was observed in serum samples under current conditions.

摘要

背景

肌醇(MI)和 D-手性肌醇(DCI)是肌醇的两种主要异构体,在葡萄糖和类固醇代谢中都至关重要。MI、DCI 或 MI/DCI 比值的不足与几种病理过程明显相关,而 MI 和 DCI 缺乏对人体标本的实际测量方法。

方法

为了同时定量血清样本中的 MI 和 DCI,建立了一种气相色谱串联质谱(GC-MS/MS)方法。在离子源、衍生剂体积和反应时间方面优化了工艺流程。通过商业标准品和临床血清验证了性能特征。

结果

该方法被证实具有灵敏度(MI 的 LOD≤30ng/mL,DCI 的 LOD≤3ng/mL)和重现性(重复分析的 RSD<6%)。MI 和 DCI 的定量测定在各自的测量范围内均具有良好的线性关系(MI:0.500-10.00μg/mL,R>0.999;DCI:0.005-0.500μg/mL,R>0.999)。MI 和 DCI 的回收率分别为 97.11%-99.35%和 107.82%-113.09%。该方法成功应用于 114 份临床标本。在当前条件下,血清样本中未观察到明显的基质效应。

相似文献

1
A rapid and validated GC-MS/MS method for simultaneous quantification of serum Myo- and D-chiro-inositol isomers.一种快速且经过验证的 GC-MS/MS 方法,用于同时定量血清肌醇和 D-手性肌醇异构体。
J Chromatogr A. 2024 Sep 13;1732:465246. doi: 10.1016/j.chroma.2024.465246. Epub 2024 Aug 8.
2
Quantification of myo-inositol, 1,5-anhydro- D-sorbitol, and D-chiro-inositol using high-performance liquid chromatography with electrochemical detection in very small volume clinical samples.使用高效液相色谱-电化学检测法对极少量临床样本中的肌醇、1,5-脱水-D-山梨醇和D-手性肌醇进行定量分析。
Biomed Chromatogr. 2015 Nov;29(11):1629-36. doi: 10.1002/bmc.3470. Epub 2015 May 26.
3
Plasma and urinary inositol isomer profiles measured by UHPLC-MS/MS reveal differences in scyllo-inositol levels between non-pregnant and pregnant women.采用 UHPLC-MS/MS 测定的血浆和尿肌醇异构体谱揭示了非孕妇和孕妇之间肌醇水平的差异。
Anal Bioanal Chem. 2020 Nov;412(28):7871-7880. doi: 10.1007/s00216-020-02919-8. Epub 2020 Sep 4.
4
Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors.D-手性肌醇或葡萄糖转运体抑制剂导致肌醇肠道吸收减少的风险。
Expert Opin Drug Metab Toxicol. 2019 Sep;15(9):697-703. doi: 10.1080/17425255.2019.1651839. Epub 2019 Aug 8.
5
Efficacy of myo-inositol and d-chiro-inositol combination on menstrual cycle regulation and improving insulin resistance in young women with polycystic ovary syndrome: A randomized open-label study.肌醇和 D-手性肌醇联合治疗多囊卵巢综合征年轻妇女月经周期调节和改善胰岛素抵抗的疗效:一项随机开放标签研究。
Int J Gynaecol Obstet. 2022 Aug;158(2):278-284. doi: 10.1002/ijgo.13971. Epub 2021 Nov 10.
6
Quantification of plasma myo-inositol using gas chromatography-mass spectrometry.使用气相色谱-质谱法定量血浆肌醇。
Clin Chim Acta. 2016 Sep 1;460:88-92. doi: 10.1016/j.cca.2016.06.022. Epub 2016 Jun 21.
7
Alternative routes for production of the drug candidate d-chiro-inositol with Corynebacterium glutamicum using endogenous or promiscuous plant enzymes.利用谷氨酸棒杆菌的内源性或杂合植物酶替代途径生产候选药物 D-手性肌醇。
Metab Eng. 2023 Jul;78:1-10. doi: 10.1016/j.ymben.2023.04.013. Epub 2023 May 3.
8
The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial.孕期补充不同肌醇立体异构体对高危患者母体妊娠期糖尿病及胎儿结局的影响:一项随机对照试验
J Matern Fetal Neonatal Med. 2020 Mar;33(5):743-751. doi: 10.1080/14767058.2018.1500545. Epub 2018 Dec 17.
9
The combined therapy with myo-inositol and D-chiro-inositol reduces the risk of metabolic disease in PCOS overweight patients compared to myo-inositol supplementation alone.与单独补充肌醇相比,肌醇和 D-手性肌醇联合治疗可降低 PCOS 超重患者代谢性疾病的风险。
Eur Rev Med Pharmacol Sci. 2012 May;16(5):575-81.
10
The diabetic rat kidney mediates inosituria and selective urinary partitioning of D-chiro-inositol.糖尿病大鼠肾脏介导肌醇尿和 D-手性肌醇的选择性尿分配。
Exp Biol Med (Maywood). 2015 Jan;240(1):8-14. doi: 10.1177/1535370214543064. Epub 2014 Jul 24.